Caris Diagnostics Appoints Vice President of Oncology Franchise to Meet Rising Demand for Molecular Diagnostics

Published: Oct 01, 2009

IRVING, Texas and PHOENIX, Oct. 1, 2009 (GLOBE NEWSWIRE) -- Caris Diagnostics ("Caris Dx"), a leading provider of integrated anatomic pathology and oncology testing services including molecular profiling and hematopathology, today announced the appointment of Chris Roberts as Vice President of the Target Now franchise. In this new role, Chris will meet the growing needs associated with Caris' expanding molecular business.

Back to news